PT Enseval Putera Megatrading Terbuka operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Enseval Putera Megatrading Terbuka with three other
drug stores in Asia:
China National Medicines Corp., Ltd.
sales of 10.08 billion Chinese Renmimbi [US$1.63 billion]
of which 101%
was Merchandise Selling),
Kalbe Farma Tbk PT
(16.00 trillion Indonesian Rupiahs [US$1.38 billion]
of which 36%
was Distribution and Logistics), and
Chuo Bussan Corporation
based in Japan
(132.25 billion Japanese Yen [US$1.30 billion]
of which 99%
was Sundry Goods).
PT Enseval Putera Megatrading Terbuka reported sales of 15.62 trillion Indonesian Rupiahs (US$1.35 billion)
December of 2013.
increase of 16.8%
versus 2012, when the company's sales were 13.37 trillion Indonesian Rupiahs.
Sales at PT Enseval Putera Megatrading Terbuka have increased during each of the previous five years
(and since 2008, sales have increased a total of 111%).
Sales of Other saw an increase
21.3% in 2013, from
1.85 trillion Indonesian Rupiahs to 2.24 trillion Indonesian Rupiahs.